Profund Vp Health Care
Profund Vp Health Care reported 59 holdings worth US$35.1M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 28, 2026
Profund Vp Health Care reported 59 holdings worth US$35.1M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Aug 28, 2026 (Form N-PORT).
- Holdings
- 59
- Value as reported
- US$35.1M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 4,223 | US$5.07M | 14.4% |
| Johnson & Johnson | 12,852 | US$3.26M | 9.3% |
| Abbvie Inc. | 9,433 | US$2.37M | 6.8% |
| Unitedhealth Group Incorporated | 4,849 | US$2.02M | 5.7% |
| Merck & Company, Inc. | 13,187 | US$1.69M | 4.8% |
| Amgen Inc. | 2,882 | US$1.04M | 3.0% |
| Thermo Fisher Scientific Inc | 1,984 | US$995K | 2.8% |
| Abbott Laboratories | 9,300 | US$844K | 2.4% |
| Gilead Sciences, Inc. | 6,628 | US$837K | 2.4% |
| Intuitive Surgical, Inc. | 1,891 | US$752K | 2.1% |
| Pfizer, Inc. | 30,430 | US$733K | 2.1% |
| Cvs Health Corporation | 6,812 | US$705K | 2.0% |
| Vertex Pharmaceuticals Incorporated | 1,355 | US$673K | 1.9% |
| Danaher Corporation | 3,363 | US$641K | 1.8% |
| Bristol-myers Squibb Company | 10,903 | US$628K | 1.8% |
| Stryker Corporation | 1,842 | US$580K | 1.7% |
| Medtronic Plc. | 6,855 | US$536K | 1.5% |
| Mckesson Corporation | 642 | US$485K | 1.4% |
| Elevance Health, Inc. | 1,159 | US$448K | 1.3% |
| The Cigna Group | 1,412 | US$389K | 1.1% |
| Boston Scientific Corporation | 7,936 | US$339K | 0.97% |
| Regeneron Pharmaceuticals, Inc. | 533 | US$332K | 0.95% |
| Hca Healthcare, Inc. | 829 | US$323K | 0.92% |
| Cardinal Health, Inc. | 1,250 | US$297K | 0.85% |
| Cencora, Inc. | 1,039 | US$294K | 0.84% |
| Edwards Lifesciences Corporation | 3,074 | US$278K | 0.79% |
| Humana Inc. | 641 | US$255K | 0.73% |
| Becton, Dickinson And Company | 1,471 | US$223K | 0.63% |
| Idexx Laboratories, Inc. | 421 | US$222K | 0.63% |
| Agilent Technologies, Inc. | 1,509 | US$200K | 0.57% |
| Waters Corporation | 524 | US$197K | 0.56% |
| Iqvia Holdings, Inc. | 891 | US$172K | 0.49% |
| Biogen Inc. | 788 | US$170K | 0.49% |
| Zoetis Inc. | 2,238 | US$161K | 0.46% |
| Centene Corporation | 2,505 | US$161K | 0.46% |
| Ge Healthcare Technologies Inc. | 2,429 | US$155K | 0.44% |
| Resmed Inc. | 774 | US$151K | 0.43% |
| Veeva Systems Inc. | 802 | US$142K | 0.41% |
| Dexcom, Inc. | 2,060 | US$139K | 0.40% |
| Mettler-toledo International, Inc. | 108 | US$138K | 0.39% |
| West Pharmaceutical Services, Inc. | 377 | US$135K | 0.39% |
| Moderna, Inc. | 1,885 | US$132K | 0.38% |
| Quest Diagnostics Incorporated | 591 | US$125K | 0.36% |
| Labcorp Holdings Inc. | 438 | US$123K | 0.35% |
| Steris Plc (ireland) | 524 | US$110K | 0.31% |
| Incyte Corporation | 896 | US$102K | 0.29% |
| Viatris Inc. | 6,218 | US$98,742 | 0.28% |
| Zimmer Biomet Holdings, Inc. | 1,033 | US$88,931 | 0.25% |
| The Cooper Companies, Inc. | 1,042 | US$74,722 | 0.21% |
| Revvity, Inc. | 596 | US$66,311 | 0.19% |
| Solventum Corporation | 786 | US$60,640 | 0.17% |
| Align Technology, Inc. | 356 | US$60,043 | 0.17% |
| Bio-techne Corp | 836 | US$59,063 | 0.17% |
| Baxter International Inc. | 2,757 | US$58,779 | 0.17% |
| Charles River Laboratories International, Inc. | 257 | US$58,285 | 0.17% |
| Insulet Corporation | 370 | US$56,333 | 0.16% |
| Henry Schein, Inc. | 517 | US$43,180 | 0.12% |
| Universal Health Services, Inc. | 285 | US$42,377 | 0.12% |
| Davita Inc. | 171 | US$38,044 | 0.11% |
Source
View original at SEC
Related